End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5126 USD | -2.34% | -19.17% | -98.11% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 44
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 4 | 100.0 % | 24 | 100.0 % | +454.42% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 24 | 100.0 % | +454.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Marc Beaudoin
COO | Chief Operating Officer | - | Jan. 24 |
Chief Tech/Sci/R&D Officer | 60 | 16-01-31 | |
Malek Chamoun
PRN | Corporate Officer/Principal | 39 | Jan. 24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Natan
BRD | Director/Board Member | 70 | 22-01-31 |
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Chief Tech/Sci/R&D Officer | 60 | 16-01-31 | |
Rabi Kiderchah
BRD | Director/Board Member | 51 | 21-10-30 |
Andrew Keller
BRD | Director/Board Member | 70 | 22-02-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,945,052 | 18,851,057 ( 99.50 %) | 0 | 99.50 % |
Stock B | 0 | 130,000 | 0 | 0 |
Company contact information
Sunshine Biopharma, Inc.
1177 Avenue of the Americas 5th Floor
10036, New York
+
http://www.sunshinebiopharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.11% | 9.71M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- SBFM Stock
- Company Sunshine Biopharma, Inc.